Generation of hiPSC-derived low threshold mechanoreceptors containing axonal termini resembling bulbous sensory nerve endings and expressing Piezo1 and Piezo2.

Bulbous sensory nerve ending Human induced pluripotent stem cells Low threshold mechanoreceptors Piezo1, Piezo2 Small molecule-derived neural precursor cells

Journal

Stem cell research
ISSN: 1876-7753
Titre abrégé: Stem Cell Res
Pays: England
ID NLM: 101316957

Informations de publication

Date de publication:
10 2021
Historique:
received: 01 06 2021
revised: 18 08 2021
accepted: 03 09 2021
pubmed: 5 10 2021
medline: 26 11 2021
entrez: 4 10 2021
Statut: ppublish

Résumé

Somatosensory low threshold mechanoreceptors (LTMRs) sense innocuous mechanical forces, largely through specialized axon termini termed sensory nerve endings, where the mechanotransduction process initiates upon activation of mechanotransducers. In humans, a subset of sensory nerve endings is enlarged, forming bulb-like expansions, termed bulbous nerve endings. There is no in vitro human model to study these neuronal endings. Piezo2 is the main mechanotransducer found in LTMRs. Recent evidence shows that Piezo1, the other mechanotransducer considered absent in dorsal root ganglia (DRG), is expressed at low level in somatosensory neurons. We established a differentiation protocol to generate, from iPSC-derived neuronal precursor cells, human LTMR recapitulating bulbous sensory nerve endings and heterogeneous expression of Piezo1 and Piezo2. The derived neurons express LTMR-specific genes, convert mechanical stimuli into electrical signals and have specialized axon termini that morphologically resemble bulbous nerve endings. Piezo2 is concentrated within these enlarged axon termini. Some derived neurons express low level Piezo1, and a subset co-express both channels. Thus, we generated a unique, iPSCs-derived human model that can be used to investigate the physiology of bulbous sensory nerve endings, and the role of Piezo1 and 2 during mechanosensation.

Identifiants

pubmed: 34607262
pii: S1873-5061(21)00382-2
doi: 10.1016/j.scr.2021.102535
pii:
doi:

Substances chimiques

Ion Channels 0
PIEZO1 protein, human 0
PIEZO2 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102535

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Shuyong Zhu (S)

Institute of Virology, Hannover Medical School, Germany; Cluster of Excellence-Resolving Infection Susceptibility (RESIST), Hannover Medical School, Germany. Electronic address: zhu.shuyong@mh-hannover.de.

Nancy Stanslowsky (N)

Department of Neurology, Hannover Medical School, Germany.

Jorge Fernández-Trillo (J)

Instituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas, Spain.

Tamrat M Mamo (TM)

Institute of Molecular Biology, Hannover Medical School, Germany.

Pengfei Yu (P)

Institute of Virology, Hannover Medical School, Germany.

Norman Kalmbach (N)

Department of Neurology, Hannover Medical School, Germany.

Birgit Ritter (B)

Institute of Virology, Hannover Medical School, Germany.

Reto Eggenschwiler (R)

Research Group Translational Hepatology and Stem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, Germany; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Germany.

Werner J D Ouwendijk (WJD)

Department of Viroscience, Erasmus Medical Center, the Netherlands.

David Mzinza (D)

Institute of Immunology, Hannover Medical School, Germany.

Likai Tan (L)

Institute of Immunology, Hannover Medical School, Germany.

Andreas Leffler (A)

Department of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Germany.

Michael Spohn (M)

The Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Germany.

Richard J P Brown (RJP)

Division of Veterinary Medicine, Paul-Ehrlich-Institute, Germany.

Kai A Kropp (KA)

Institute of Virology, Hannover Medical School, Germany.

Volkhard Kaever (V)

Research Core Unit Metabolomics, Institute of Pharmacology, Hannover Medical School, Germany.

Teng-Cheong Ha (TC)

Institute of Experimental Hematology, Hannover Medical School, Germany.

Pratibha Narayanan (P)

Max Planck Institute of Experimental Medicine, Germany.

Adam Grundhoff (A)

The Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Germany.

Reinhold Förster (R)

Cluster of Excellence-Resolving Infection Susceptibility (RESIST), Hannover Medical School, Germany; Institute of Immunology, Hannover Medical School, Germany.

Axel Schambach (A)

Institute of Experimental Hematology, Hannover Medical School, Germany; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, MA, USA.

Georges M G M Verjans (GMGM)

Department of Viroscience, Erasmus Medical Center, the Netherlands.

Manuela Schmidt (M)

Max Planck Institute of Experimental Medicine, Germany.

Andreas Kispert (A)

Institute of Molecular Biology, Hannover Medical School, Germany.

Tobias Cantz (T)

Research Group Translational Hepatology and Stem Cell Biology, Cluster of Excellence REBIRTH, Hannover Medical School, Germany; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Germany.

Ana Gomis (A)

Instituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas, Spain.

Florian Wegner (F)

Department of Neurology, Hannover Medical School, Germany.

Abel Viejo-Borbolla (A)

Institute of Virology, Hannover Medical School, Germany; Cluster of Excellence-Resolving Infection Susceptibility (RESIST), Hannover Medical School, Germany. Electronic address: viejo-borbolla.abel@mh-hannover.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH